On this episode of ID the Future, Dr. Michael Behe talks with Casey Luskin about recent findings that support his argument in The Edge of Evolution. Dr. Behe explains why Chloroquine, a drug that treats malaria, presents a good opportunity to study the limits of random mutation and natural selection, and how his conclusions inspired so much backlash — including misrepresentation of his argument — from his critics.
When ID skeptics object to the arguments of ID proponents that the incredible fine tuning of the universe is evidence for design they often...
On this episode of ID the Future, Discovery Institute President Bruce Chapman asks David Berlinski how to address the problem of dissent in science....
A recent ABC News article says the latest research about the hominid species Homo naledi "erases the idea of human exceptionalism." A new Netflix...